Case number 2020-2229
Bristol-Myers Squibb Company v. Sigmapharm Laboratories > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 12, 2021 | 82 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [804983] [20-2229, 20-2252, 20-2258] [MVH] [Entered: 10/12/2021 02:18 PM] (1) |
| Sep 5, 2021 | 0 | BRISTOL-MYERS SQUIBB COMPANY v. SIGMAPHARM LABORATORIES [OPINION] [nonprecedential] (0) |
| Sep 3, 2021 | 81 | JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [797066] [20-2229, 20-2252, 20-2258] [MVH] [Entered: 09/03/2021 09:51 AM] (1) |
| Sep 3, 2021 | 80 | OPINION filed for the court by Moore, Chief Judge; Newman, Circuit Judge and O'Malley, Circuit Judge. Nonprecedential Opinion. Service as of this date by the Clerk of Court. [797065] [20-2229, 20-2252, 20-2258] [MVH] [Entered: 09/03/2021 09:50 AM] (3) |
| Sep 2, 2021 | 79 | Submitted after ORAL ARGUMENT to Panel: Moore, Chief Judge; Newman, Circuit Judge and O'Malley, Circuit Judge.Arguing counsel: Mr. Paul Hilger Kochanski for HEC Pharm USA Inc. and Sunshine Lake Pharma Co. Ltd., Mr. Donald J. Mizerk for Sigmapharm Laboratories, LLC, Mr. Peter Branko Pejic for Unichem Laboratories, Ltd. and William F. Lee for Pfizer Inc. and Bristol-Myers Squibb Company.Oral Argument Audio available here. [796915] [JCP] [Entered: 09/02/2021 02:02 PM] (0) |
| Aug 18, 2021 | 78 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: Unichem Laboratories, Ltd.'s filings [74] and [75] used an impermissible electronic signature format. CORRECTION: Please ensure future electronic signatures comply with Fed. Cir. R. 25(g). THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [793566] [MJL] [Entered: 08/18/2021 09:19 AM] (0) |
| Aug 17, 2021 | 77 | Response to notice of oral argument from Appellant Sigmapharm Laboratories, LLC. Service: 08/17/2021 by email. [793496] [20-2229] [Donald Mizerk] [Entered: 08/17/2021 05:31 PM] (1) |
| Aug 17, 2021 | 76 | Notice to Sigmapharm Laboratories, LLC: The record of this case indicates that no Response to Notice of Oral Argument under FCR 34(e) has been filed. Failure to file required documents may result in dismissal or other action as deemed appropriate by the court. See FCR 25(h). Service as of this date by the Clerk of Court. [793464] [MJL] [Entered: 08/17/2021 04:11 PM] (0) |
| Aug 16, 2021 | 75 | Certification of Compliance with Revised Protocols for In-Person Argument for Appellant Unichem Laboratories, Ltd.. Service: 08/16/2021 by email. [793003] [20-2229] [Peter Pejic] [Entered: 08/16/2021 05:08 PM] (2) |
| Aug 16, 2021 | 74 | Response to notice of oral argument from Appellant Unichem Laboratories, Ltd.. Service: 08/16/2021 by email. [793000] [20-2229] [Peter Pejic] [Entered: 08/16/2021 05:02 PM] (1) |
| Aug 16, 2021 | 73 | Response to notice of oral argument from Appellees Bristol-Myers Squibb Company and Pfizer Inc.. Service: 08/16/2021 by email. [792957] [20-2229] [William Lee] [Entered: 08/16/2021 03:46 PM] (3) |
| Aug 16, 2021 | 72 | Certification of Compliance with Revised Protocols for In-Person Argument for Appellant Sigmapharm Laboratories, LLC. Service: 08/16/2021 by email. [792806] [20-2229] [Donald Mizerk] [Entered: 08/16/2021 11:26 AM] (2) |
| Aug 16, 2021 | 71 | Certification of Compliance with Revised Protocols for In-Person Argument for Appellants HEC Pharm USA Inc. and Sunshine Lake Pharma Co. Ltd.. Service: 08/16/2021 by email. [792789] [20-2229] [Paul Kochanski] [Entered: 08/16/2021 10:41 AM] (2) |
| Aug 16, 2021 | 70 | Response to notice of oral argument from Appellants HEC Pharm USA Inc. and Sunshine Lake Pharma Co. Ltd.. Service: 08/16/2021 by email. [792788] [20-2229] [Paul Kochanski] [Entered: 08/16/2021 10:35 AM] (1) |
| Aug 12, 2021 | 69 | Notice of intent to use visual aids at oral argrument for Appellant Sigmapharm Laboratories, LLC. Service: 08/12/2021 by email. [792376] [20-2229] [Donald Mizerk] [Entered: 08/12/2021 07:39 PM] (9) |
| Aug 12, 2021 | 68 | Counsel are advised that the Federal Circuit has issued Revised Protocols for In-Person Arguments. All arguing counsel, including counsel who have already filed a Response to Notice of Oral Argument, must file revised Form 33A no later than 08/16/2021. Form 33A may be attached to the Response to Notice of Oral Argument or filed as Other Document. [792212] [MJL] [Entered: 08/12/2021 10:51 AM] (0) |
| Aug 10, 2021 | 67 | ORDER filed granting Appellants Sigmapharm Laboratories, LLC, HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd. and Unichem Laboratories, Ltd motion to allow argument [66]. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [791823] [MVH] [Entered: 08/10/2021 05:34 PM] (2) |
| Aug 9, 2021 | 66 | MOTION of Appellants Sigmapharm Laboratories, LLC, Sunshine Lake Pharma Co. Ltd., Unichem Laboratories, Ltd. and HEC Pharm USA Inc. to allow argument. Service: 08/09/2021 by email. [791491] [20-2229] [Donald Mizerk] [Entered: 08/09/2021 04:08 PM] (15) |
| Jul 26, 2021 | 65 | ORDER filed denying motion to treat appeals as companion cases for oral argument [62] filed by Sigmapharm Laboratories, LLC, HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd. and Unichem Laboratories, Ltd. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [788735] [MVH] [Entered: 07/26/2021 03:44 PM] (2) |
| Jul 26, 2021 | 64 | RESPONSE of Appellees Bristol-Myers Squibb Company and Pfizer Inc. to Doc No. [62]. Service: 07/26/2021 by email. [788628] [20-2229] [William Lee] [Entered: 07/26/2021 12:26 PM] (22) |
| Jul 21, 2021 | 63 | NOTICE OF ORAL ARGUMENT. Panel: 2109G. Case scheduled September 2, 2021. Response to Notice of Oral Argument due: 08/16/2021. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [787827] [MVH] [Entered: 07/21/2021 05:17 PM] (2) |
| Jul 16, 2021 | 62 | MOTION of Appellants Sigmapharm Laboratories, LLC, Unichem Laboratories, Ltd., Sunshine Lake Pharma Co. Ltd. and HEC Pharm USA Inc. to treat as companion cases. Service: 07/16/2021 by email. [786843] [20-2229] [Donald Mizerk] [Entered: 07/16/2021 04:25 PM] (16) |
| Jun 11, 2021 | 61 | The following conflict dates submitted by William F. Lee for Pfizer Inc. and Bristol-Myers Squibb Company have been accepted by the court: 09/03/2021, 12/06/2021, 12/07/2021, 12/08/2021, 12/09/2021, 12/10/2021. [779862] [MJL] [Entered: 06/11/2021 04:22 PM] (0) |
| Jun 4, 2021 | 60 | 6 paper copies of Doc. No. [41] received from Appellants HEC Pharm USA Inc., Sigmapharm Laboratories, LLC, Sunshine Lake Pharma Co. Ltd. and Unichem Laboratories, Ltd.. [778832] [VDW] [Entered: 06/07/2021 02:48 PM] (0) |
| Jun 4, 2021 | 59 | 6 paper copies of Doc. No. [49] received from Appellant Unichem Laboratories, Ltd.. [778828] [VDW] [Entered: 06/07/2021 02:46 PM] (0) |
| Jun 4, 2021 | 58 | 6 paper copies of Doc. No. [37], [21] received from Appellants Sunshine Lake Pharma Co. Ltd., HEC Pharm USA Inc. [778826]--[Edited 07/14/2021 by MJL to correct party filers] [VDW] [Entered: 06/07/2021 02:44 PM] (0) |
| Jun 4, 2021 | 57 | Notice from Appellant Unichem Laboratories, Ltd. regarding conflicts with oral argument. None. Service: 06/04/2021 by email. [778559] [20-2229] [Paul Braier] [Entered: 06/04/2021 01:40 PM] (1) |
| Jun 4, 2021 | 56 | Notice from Appellees Bristol-Myers Squibb Company and Pfizer Inc. regarding conflicts with oral argument. Service: 06/04/2021 by email. [778531] [20-2229] [William Lee] [Entered: 06/04/2021 11:51 AM] (3) |
| Jun 4, 2021 | 55 | Notice from Appellants HEC Pharm USA Inc. and Sunshine Lake Pharma Co. Ltd. regarding conflicts with oral argument. None. Service: 06/04/2021 by email. [778525] [20-2229] [Paul Kochanski] [Entered: 06/04/2021 11:45 AM] (1) |
| Jun 4, 2021 | 53 | Notice from Appellant Sigmapharm Laboratories, LLC regarding conflicts with oral argument. None. Service: 06/04/2021 by email. [778508] [20-2229] [Donald Mizerk] [Entered: 06/04/2021 11:03 AM] (1) |
| Jun 3, 2021 | 54 | 6 paper copies of Doc. No. [39] received from Appellant Sigmapharm Laboratories, LLC. [778510] [VDW] [Entered: 06/04/2021 11:04 AM] (0) |
| Jun 3, 2021 | 52 | 6 paper copies of Doc. No. [48] received from Appellant Unichem Laboratories, Ltd.. [778479] [VDW] [Entered: 06/04/2021 09:29 AM] (0) |
| Jun 3, 2021 | 51 | 6 paper copies of Doc. No. [46] received from Appellant Sigmapharm Laboratories, LLC. [778473] [VDW] [Entered: 06/04/2021 09:20 AM] (0) |
| Jun 1, 2021 | 50 | 6 paper copies of Doc. No. [34] received from Appellees Bristol-Myers Squibb Company and Pfizer Inc.. [778121] [VDW] [Entered: 06/02/2021 01:57 PM] (0) |
| May 28, 2021 | 49 | MODIFIED ENTRY: CORRECTED REPLY BRIEF FILED by Appellant Unichem Laboratories, Ltd.. Service: 05/28/2021 by email. [777657]--[Edited 06/02/2021 by KMH - compliance review complete] [Paul Braier] [Entered: 05/28/2021 03:59 PM] (39) |
| May 28, 2021 | 48 | MODIFIED ENTRY: CORRECTED OPENING BRIEF FILED by Appellant Unichem Laboratories, Ltd.. Service: 05/28/2021 by email. [777656]--[Edited 06/02/2021 by KMH - compliance review complete] [Paul Braier] [Entered: 05/28/2021 03:58 PM] (360) |
| May 28, 2021 | 47 | Notice from Appellant Unichem Laboratories, Ltd. Notice of Correction to Brief (Doc. No. 31) and Reply Brief (Doc. No. 38). Service: 05/28/2021 by email. [777655] [20-2229] [Paul Braier] [Entered: 05/28/2021 03:55 PM] (3) |
| May 28, 2021 | 46 | MODIFIED ENTRY: CORRECTED OPENING BRIEF FILED by Appellant Sigmapharm Laboratories, LLC. Service: 05/28/2021 by email. [777587]--[Edited 06/02/2021 by KMH - compliance review complete] [Marc Wezowski] [Entered: 05/28/2021 01:12 PM] (349) |
| May 28, 2021 | 45 | Notice of Correction to Doc No. [30] for Appellant Sigmapharm Laboratories, LLC. Service: 05/28/2021 by email. [777585] [20-2229] [Marc Wezowski] [Entered: 05/28/2021 01:10 PM] (2) |
| May 28, 2021 | 44 | Notice to counsel: The Clerk's Office directs that outstanding paper copies of all briefs and appendices in this case must be submitted on or before June 7, 2021. See Administrative Order No. 20-01 (Mar. 20, 2020). [777533] [KMH] [Entered: 05/28/2021 10:00 AM] (0) |
| May 28, 2021 | 43 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [777531] [KMH] [Entered: 05/28/2021 09:57 AM] (1) |
| May 26, 2021 | 41 | MODIFIED ENTRY: APPENDIX FILED by Appellants HEC Pharm USA Inc., Sigmapharm Laboratories, LLC, Sunshine Lake Pharma Co. Ltd., Unichem Laboratories, Ltd. and Appellees Bristol-Myers Squibb Company and Pfizer Inc.. Service: 05/26/2021 by email. [777333] --[Edited 05/28/2021 by KMH - compliance review complete] [Marc Wezowski] [Entered: 05/26/2021 05:03 PM] (2434) |
| May 26, 2021 | 42 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellees Bristol-Myers Squibb Company, Pfizer Inc. and Appellants HEC Pharm USA Inc., Sigmapharm Laboratories, LLC, Sunshine Lake Pharma Co. Ltd. and Unichem Laboratories, Ltd.. Service: 05/26/2021 by email. [777334] [20-2229] [Marc Wezowski] [Entered: 05/26/2021 05:04 PM] (2) |
| May 26, 2021 | 40 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellees Bristol-Myers Squibb Company and Pfizer Inc.. Service: 05/26/2021 by email. [777253] [20-2229] [William Lee] [Entered: 05/26/2021 02:20 PM] (4) |
| May 19, 2021 | 39 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellant Sigmapharm Laboratories, LLC. Service: 05/19/2021 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [776094] --[Edited 05/24/2021 by KMH - compliance review complete] [Marc Wezowski] [Entered: 05/19/2021 05:04 PM] (36) |
| May 19, 2021 | 38 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellant Unichem Laboratories, Ltd.. Service: 05/19/2021 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [776080] --[Edited 05/24/2021 by KMH - compliance review complete] This document has been corrected. See Doc No. [49] [Paul Braier] [Entered: 05/19/2021 04:21 PM] (39) |
| May 19, 2021 | 37 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellants HEC Pharm USA Inc. and Sunshine Lake Pharma Co. Ltd. Service: 05/19/2021 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [775958] --[Edited 05/24/2021 by KMH - compliance review complete] [Paul Kochanski] [Entered: 05/19/2021 11:42 AM] (33) |
| Apr 12, 2021 | 36 | **TEXT ONLY** ORDER granting motion to extend time to file brief [35] filed by Appellants Sigmapharm Laboratories, LLC, Sunshine Lake Pharma Co. Ltd. and Unichem Laboratories, Ltd. The reply briefs are due 05/19/2021. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [767950] [KMH] [Entered: 04/12/2021 09:53 AM] (0) |
| Apr 8, 2021 | 35 | MOTION of Appellants Sigmapharm Laboratories, LLC, Sunshine Lake Pharma Co. Ltd. and Unichem Laboratories, Ltd. to extend the time to 05/19/2021 to file brief. Service: 04/08/2021 by email. [767594] [20-2229] [Philip Segrest] [Entered: 04/08/2021 04:48 PM] (25) |
| Mar 29, 2021 | 34 | MODIFIED ENTRY: RESPONSE BRIEF FILED by Appellees Bristol-Myers Squibb Company and Pfizer Inc.. Service: 03/29/2021 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [765473] --[Edited 04/02/2021 by KMH - compliance review complete] [William Lee] [Entered: 03/29/2021 04:16 PM] (101) |
| Feb 16, 2021 | 33 | ORDER filed granting [32] the motion. The appellees' response brief, not to exceed 18,000 words, is due within 40 days of the date of filing of this order. Service as of this date by the Clerk of Court. [756190] [LMS] [Entered: 02/16/2021 11:26 AM] (2) |
| Jan 27, 2021 | 32 | MOTION of Appellee Bristol-Myers Squibb Company to Expand the Word Limit for Response Brief. Service: 01/27/2021 by email. [752189] [20-2229] [William Lee] [Entered: 01/27/2021 05:04 PM] (14) |
| Jan 22, 2021 | 31 | MODIFIED ENTRY: CORRECTED BRIEF FILED by Appellant Unichem Laboratories, Ltd.. Service: 01/22/2021 by email. [751087] --[Edited 01/25/2021 by KMH - compliance review complete] [Paul Braier] [Entered: 01/22/2021 02:22 PM] (359) |
| Jan 21, 2021 | 30 | MODIFIED ENTRY: CORRECTED BRIEF FILED by Appellant Sigmapharm Laboratories, LLC. Service: 01/21/2021 by email. [750722] --[Edited 01/25/2021 by KMH - compliance review complete] [Philip Segrest] [Entered: 01/21/2021 04:49 PM] (349) |
| Jan 14, 2021 | 29 | ORDER filed ECF Nos. 22 [22] and 23 [23] are stricken. Unichem and Sigmapharm are directed to file corrected opening briefs, not to exceed 14,000 words including incorporated material, no later than 30 days from the date of this order. Appellees' motion [27] is denied without prejudice. Service as of this date by the Clerk of Court. [749575] [LMS] [Entered: 01/14/2021 03:47 PM] (2) |
| Jan 6, 2021 | 28 | ORDER granting motion to extend time to file brief [26] filed by Appellees Pfizer Inc. and Bristol-Myers Squibb Company. The response brief is due 03/25/2021. Service as of this date by the Clerk of Court. [747490] [LMS] [Entered: 01/06/2021 04:32 PM] (2) |
| Jan 5, 2021 | 27 | MOTION of Appellees Bristol-Myers Squibb Company and Pfizer Inc. to Expand the Word Limit for Response Brief. Service: 01/05/2021 by email. [746931] [20-2229] [William Lee] [Entered: 01/05/2021 12:50 PM] (15) |
| Jan 5, 2021 | 26 | MOTION of Appellees Bristol-Myers Squibb Company and Pfizer Inc. to extend the time to 03/25/2021 to file brief. Service: 01/05/2021 by email. [746926] [20-2229] [William Lee] [Entered: 01/05/2021 12:43 PM] (11) |
| Jan 5, 2021 | 25 | Amended Certificate of Interest for Appellees Bristol-Myers Squibb Company and Pfizer Inc.. Service: 01/05/2021 by email. [746921] [20-2229] [William Lee] [Entered: 01/05/2021 12:39 PM] (3) |
| Dec 30, 2020 | 24 | Entry of appearance for Katherine P. Kieckhafer as counsel for Appellees Bristol-Myers Squibb Company and Pfizer Inc.. Service: 12/30/2020 by email. [746056] [20-2229] [Katherine Kieckhafer] [Entered: 12/30/2020 03:18 PM] (1) |
| Dec 28, 2020 | 23 | MODIFIED ENTRY: BRIEF FILED by Appellant Sigmapharm Laboratories, LLC. Service: 12/28/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [745608] --[Edited 01/06/2021 by KMH - compliance review complete] Stricken pursuant to the court's order. See Doc No. [29] [Marc Wezowski] [Entered: 12/28/2020 06:34 PM] (0) |
| Dec 28, 2020 | 22 | MODIFIED ENTRY: BRIEF FILED by Appellant Unichem Laboratories, Ltd.. Service: 12/28/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [745559] --[Edited 01/06/2021 by KMH - compliance review complete] Stricken pursuant to the court's order. See Doc No. [29] [Paul Braier] [Entered: 12/28/2020 04:57 PM] (0) |
| Dec 28, 2020 | 21 | MODIFIED ENTRY: BRIEF FILED by Appellants HEC Pharm USA Inc. and Sunshine Lake Pharma Co. Ltd.. Service: 12/28/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [745545] --[Edited 01/06/2021 by KMH - compliance review complete] [Paul Kochanski] [Entered: 12/28/2020 04:23 PM] (189) |
| Nov 17, 2020 | 20 | ORDER filed denying [11] motion to treat as companion cases. The stay of briefing is lifted. Appellants' opening briefs are due 12/28/2020. Service as of this date by the Clerk of Court. [736280]--[Edited 11/18/2020 by KMH to correct docket text] [NL] [Entered: 11/17/2020 11:32 AM] (2) |
| Nov 5, 2020 | 19 | ORDER staying the briefing schedule pending disposition of the motion to treat the consolidated appeals as companion cases. The motion for an extension of time [15] is denied as moot. Service as of this date by the Clerk of Court. [733796] [LMS] [Entered: 11/05/2020 09:42 AM] (2) |
| Nov 4, 2020 | 18 | Letter from Appellants HEC Pharm USA Inc. and Sunshine Lake Pharma Co. Ltd. Confirmation that Sunshine Lake Pharma Co. Ltd. and HEC Pharm USA Inc. join with Reply by Sigmapharm in Response to Appellees Opposition to Treat Appeals as Companion Cases for Briefing and Argument. Service: 11/04/2020 by email. [733668] [20-2229] [Paul Kochanski] [Entered: 11/04/2020 03:28 PM] (4) |
| Nov 4, 2020 | 17 | Letter from Appellant Unichem Laboratories, Ltd. Confirmation that Unichem joins with Reply by Sigmpharm in Response to Appellees Opposition to Treat Appeals as Companion Cases for Briefing and Argument. Service: 11/04/2020 by email. [733642] [20-2229] [Paul Braier] [Entered: 11/04/2020 02:25 PM] (5) |
| Nov 2, 2020 | 16 | REPLY of Appellant Sigmapharm Laboratories, LLC to response [14]. Service: 11/02/2020 by email. [733099] [20-2229] [Marc Wezowski] [Entered: 11/02/2020 06:25 PM] (18) |
| Oct 30, 2020 | 15 | MOTION of Appellants Sigmapharm Laboratories, LLC, Sunshine Lake Pharma Co. Ltd. and Unichem Laboratories, Ltd. to extend the time to 12/14/2020 to file brief. Service: 10/30/2020 by email. [732624] [20-2229] [Paul Braier] [Entered: 10/30/2020 03:14 PM] (17) |
| Oct 26, 2020 | 14 | RESPONSE of Appellees Bristol-Myers Squibb Company and Pfizer Inc. to the motion to treat as companion case [11]. Service: 10/26/2020 by email. [731392] [20-2229] [William Lee] [Entered: 10/26/2020 02:19 PM] (110) |
| Oct 22, 2020 | 13 | Letter from Appellants HEC Pharm USA Inc. and Sunshine Lake Pharma Co. Ltd. Confirmation that Defendants-Appellants Sunshine Lake Pharma Co. Ltd. and HEC Pharm USA Inc. join with the Motion by Sigmapharm to Treat Appeals as Companion Cases for Briefing and Argument. Service: 10/22/2020 by email. [730795] [20-2229] [Paul Kochanski] [Entered: 10/22/2020 11:59 AM] (4) |
| Oct 21, 2020 | 12 | Letter from Appellant Unichem Laboratories, Ltd. Confirmation that Unichem joins with Motion by Sigmapharm to Treat Appeals as Companion Cases for Briefing and Argument. Service: 10/21/2020 by email. [730719] [20-2229] [Paul Braier] [Entered: 10/21/2020 05:58 PM] (5) |
| Oct 14, 2020 | 11 | MOTION of Appellant Sigmapharm Laboratories, LLC to treat as companion cases. Service: 10/14/2020 by email. [728742] [20-2229] [Marc Wezowski] [Entered: 10/14/2020 06:43 PM] (127) |
| Sep 30, 2020 | 10 | Note to File: The following cases are consolidated: 20-2229 Lead with 20-2252 and 20-2258 Consolidated Member Cases. The parties must file all documents in the lead appeal only. [725424] [20-2229, 20-2252, 20-2258] [KMH] [Entered: 09/30/2020 11:08 AM] (0) |
| Sep 30, 2020 | 9 | ORDER The revised official caption and short caption are reflected in this order. Appeal Nos. 2020-2229, 2020-2252, and 2020-2258 are consolidated, and thus one set of briefs should be filed for the three appeals. Appellants' opening briefs are due no later than November 13, 2020. Service as of this date by the Clerk of Court. [725322] [20-2229, 20-2252, 20-2258] [LMS] [Entered: 09/30/2020 08:30 AM] (2) |
| Sep 16, 2020 | 8 | Objection to the official caption by Appellant Sigmapharm Laboratories, LLC. Service: 09/16/2020 by email. [722290] [20-2229] [Marc Wezowski] [Entered: 09/16/2020 05:34 PM] (5) |
| Sep 16, 2020 | 7 | Docketing Statement for the Appellant Sigmapharm Laboratories, LLC. Service: 09/16/2020 by email. [722277] [20-2229] [Marc Wezowski] [Entered: 09/16/2020 05:13 PM] (2) |
| Sep 16, 2020 | 6 | Certificate of Interest for Appellant Sigmapharm Laboratories, LLC. Service: 09/16/2020 by email. [722274] [20-2229] [Marc Wezowski] [Entered: 09/16/2020 05:11 PM] (3) |
| Sep 16, 2020 | 5 | Entry of appearance for Marc R. Wezowski; Don J. Mizerk; Philip D. Segrest, Jr.; Dustin L. Taylor; Thomas P. Heneghan as counsel for Appellant Sigmapharm Laboratories, LLC. Service: 09/16/2020 by email. [722271] [20-2229] [Marc Wezowski] [Entered: 09/16/2020 05:08 PM] (2) |
| Sep 16, 2020 | 4 | Docketing Statement for the Appellees Bristol-Myers Squibb Company and Pfizer Inc.. Service: 09/16/2020 by email. [722168] [20-2229] [William Lee] [Entered: 09/16/2020 12:45 PM] (2) |
| Sep 16, 2020 | 3 | Certificate of Interest for Appellees Bristol-Myers Squibb Company and Pfizer Inc.. Service: 09/16/2020 by email. [722166] [20-2229] [William Lee] [Entered: 09/16/2020 12:44 PM] (3) |
| Sep 16, 2020 | 2 | Entry of appearance for William F. Lee; Kevin S. Prussia; Andrew J. Danford; Timothy A. Cook; Amy K. Wigmore; Madeleine C. Laupheimer; Heather M. Petruzzi as counsel for Appellees Bristol-Myers Squibb Company and Pfizer Inc.. Service: 09/16/2020 by email. [722164] [20-2229] [William Lee] [Entered: 09/16/2020 12:42 PM] (2) |
| Sep 2, 2020 | 1 | Appeal docketed. Received: 08/28/2020. [719079]Entry of Appearance is due on 09/16/2020. Certificate of Interest is due on 09/16/2020. Docketing Statement is due on 09/16/2020. Appellant's brief is due on 11/02/2020. [KMH] [Entered: 09/02/2020 10:56 AM] (85) |
